THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS

Pathum Sookaromdee; Viroj Wiwanitkit

doi:10.26650/IUITFD.1133431

Editöre Mektup

Yıl 2022, Cilt: 85 Sayı: 4, 585 - 586, 28.10.2022

Pathum Sookaromdee , Viroj Wiwanitkit

https://doi.org/10.26650/IUITFD.1133431

Öz

Kaynakça

1. Hsia W. Emerging new coronavirus infection in Wuhan, China: situation in early 2020. Case Study Case Rep 2020;10:8-9. google scholar
2. Soleimanpour S, Yaghoubi A. COVID-19 vaccine: where are we now and where should we go? Expert Rev Vaccines 2021;20(1):23-44. [CrossRef] google scholar
3. Shekhar R, Garg I, Pal S, Kottewar S, Sheikh AB. COVID-19 Vaccine booster: to boost or not to boost. Infect Dis Rep 2021;13(4):924-929. [CrossRef] google scholar
4. Krause PR, Fleming TR, Peto R, Longini IM, Figueroa JP, Sterne JAC, et al. Considerations in boosting COVID-19 vaccine immune responses. Lancet 2021;398(10308):1377-80. [CrossRef] google scholar
5. Mahase E. COVID-19: third vaccine dose boosts immune response but may not be needed, say researchers. BMJ 2021;373:n1659. [CrossRef] google scholar
6. Burki TK. Fourth dose of COVID-19 vaccines in Israel. Lancet Respir Med 2022;10(2):e19. [CrossRef] google scholar
7. Abedon AT, Teles MS, Alejo JL, Kim JD, Mitchell J, Chiang TPY, et al. Improved antibody response after a fifth dose of a SARS-CoV-2 vaccine in solid organ transplant recipients: a case series. Transplantation 2022;106(5):e262-3. [CrossRef] google scholar
8. Osmanodja B, Ronicke S, Budde K, Jens A, Hammett C, Koch N, et al. Serological response to three, four and five doses of SARS-CoV-2 vaccine in kidney transplant recipients. J Clin Med 2022;11(9):2565. [CrossRef] google scholar
9. Sookaromdee P, Wiwanitkit V. New COVID-19 vaccines, its cost and shelf life: a cost effectiveness analysis. Arch Med Res 2021;52(4):453. [CrossRef] google scholar
10. Yasri S, Wiwanitkit V. Expected response to the additional third dose of COVID-19 vaccine based on different complete standard vaccination background. Int J Physiol Pathophysiol Pharmacol 2022;14(1):1-3. google scholar

THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS

Yıl 2022, Cilt: 85 Sayı: 4, 585 - 586, 28.10.2022

Pathum Sookaromdee , Viroj Wiwanitkit

https://doi.org/10.26650/IUITFD.1133431

Öz

Expected seroprotection rate after the sixth dose COVID-19 vaccine: a note from clinical model on kidney transplant recipients
Expected seroprotection rate after the sixth dose COVID-19 vaccine: a note from clinical model on kidney transplant recipients
Expected seroprotection rate after the sixth dose COVID-19 vaccine: a note from clinical model on kidney transplant recipients
Expected seroprotection rate after the sixth dose COVID-19 vaccine: a note from clinical model on kidney transplant recipients
Expected seroprotection rate after the sixth dose COVID-19 vaccine: a note from clinical model on kidney transplant recipients
Expected seroprotection rate after the sixth dose COVID-19 vaccine: a note from clinical model on kidney transplant recipients

Anahtar Kelimeler

covid , vaccine , renal , transplant , dose

Kaynakça

1. Hsia W. Emerging new coronavirus infection in Wuhan, China: situation in early 2020. Case Study Case Rep 2020;10:8-9. google scholar
2. Soleimanpour S, Yaghoubi A. COVID-19 vaccine: where are we now and where should we go? Expert Rev Vaccines 2021;20(1):23-44. [CrossRef] google scholar
3. Shekhar R, Garg I, Pal S, Kottewar S, Sheikh AB. COVID-19 Vaccine booster: to boost or not to boost. Infect Dis Rep 2021;13(4):924-929. [CrossRef] google scholar
4. Krause PR, Fleming TR, Peto R, Longini IM, Figueroa JP, Sterne JAC, et al. Considerations in boosting COVID-19 vaccine immune responses. Lancet 2021;398(10308):1377-80. [CrossRef] google scholar
5. Mahase E. COVID-19: third vaccine dose boosts immune response but may not be needed, say researchers. BMJ 2021;373:n1659. [CrossRef] google scholar
6. Burki TK. Fourth dose of COVID-19 vaccines in Israel. Lancet Respir Med 2022;10(2):e19. [CrossRef] google scholar
7. Abedon AT, Teles MS, Alejo JL, Kim JD, Mitchell J, Chiang TPY, et al. Improved antibody response after a fifth dose of a SARS-CoV-2 vaccine in solid organ transplant recipients: a case series. Transplantation 2022;106(5):e262-3. [CrossRef] google scholar
8. Osmanodja B, Ronicke S, Budde K, Jens A, Hammett C, Koch N, et al. Serological response to three, four and five doses of SARS-CoV-2 vaccine in kidney transplant recipients. J Clin Med 2022;11(9):2565. [CrossRef] google scholar
9. Sookaromdee P, Wiwanitkit V. New COVID-19 vaccines, its cost and shelf life: a cost effectiveness analysis. Arch Med Res 2021;52(4):453. [CrossRef] google scholar
10. Yasri S, Wiwanitkit V. Expected response to the additional third dose of COVID-19 vaccine based on different complete standard vaccination background. Int J Physiol Pathophysiol Pharmacol 2022;14(1):1-3. google scholar

Toplam 10 adet kaynakça vardır.

Ayrıntılar

Birincil Dil	İngilizce
Konular	Sağlık Kurumları Yönetimi
Bölüm	Editöre Mektup
Yazarlar	Pathum Sookaromdee 0000-0002-8859-5322 Viroj Wiwanitkit 0000-0003-1039-3728
Gönderilme Tarihi	20 Haziran 2022
Yayımlanma Tarihi	28 Ekim 2022
Yayımlandığı Sayı	Yıl 2022 Cilt: 85 Sayı: 4

Kaynak Göster

APA	Sookaromdee, P., & Wiwanitkit, V. (2022). THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS. Journal of Istanbul Faculty of Medicine, 85(4), 585-586. https://doi.org/10.26650/IUITFD.1133431
AMA	Sookaromdee P, Wiwanitkit V. THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS. İst Tıp Fak Derg. Ekim 2022;85(4):585-586. doi:10.26650/IUITFD.1133431
Chicago	Sookaromdee, Pathum, ve Viroj Wiwanitkit. “THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS”. Journal of Istanbul Faculty of Medicine 85, sy. 4 (Ekim 2022): 585-86. https://doi.org/10.26650/IUITFD.1133431.
EndNote	Sookaromdee P, Wiwanitkit V (01 Ekim 2022) THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS. Journal of Istanbul Faculty of Medicine 85 4 585–586.
IEEE	P. Sookaromdee ve V. Wiwanitkit, “THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS”, İst Tıp Fak Derg, c. 85, sy. 4, ss. 585–586, 2022, doi: 10.26650/IUITFD.1133431.
ISNAD	Sookaromdee, Pathum - Wiwanitkit, Viroj. “THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS”. Journal of Istanbul Faculty of Medicine 85/4 (Ekim2022), 585-586. https://doi.org/10.26650/IUITFD.1133431.
JAMA	Sookaromdee P, Wiwanitkit V. THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS. İst Tıp Fak Derg. 2022;85:585–586.
MLA	Sookaromdee, Pathum ve Viroj Wiwanitkit. “THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS”. Journal of Istanbul Faculty of Medicine, c. 85, sy. 4, 2022, ss. 585-6, doi:10.26650/IUITFD.1133431.
Vancouver	Sookaromdee P, Wiwanitkit V. THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS. İst Tıp Fak Derg. 2022;85(4):585-6.